Reduced Intensity Donor Stem Cell Transplant in Treating Patients With High Risk Acute Lymphocytic Leukemia in Complete Remission
Conditions
- Adult Acute Lymphoblastic Leukemia in Remission
- Childhood Acute Lymphoblastic Leukemia in Remission
- Recurrent Adult Acute Lymphoblastic Leukemia
- Recurrent Childhood Acute Lymphoblastic Leukemia
Interventions
- PROCEDURE: nonmyeloablative allogeneic hematopoietic stem cell transplantation
- BIOLOGICAL: donor lymphocytes
- DRUG: cyclosporine
- RADIATION: total-body irradiation
- DRUG: fludarabine phosphate
- DRUG: mycophenolate mofetil
- OTHER: laboratory biomarker analysis
- PROCEDURE: peripheral blood stem cell transplantation
Sponsor
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
Collaborators